FERGUSON WELLMAN CAPITAL MANAGEMENT, INC has added 79,430 shares of $COR to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $COR.
CENCORA Hedge Fund Activity
We have seen 583 institutional investors add shares of CENCORA stock to their portfolio, and 574 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WALGREENS BOOTS ALLIANCE, INC. removed 9,600,000 shares (-48.0%) from their portfolio in Q1 2025, for an estimated $2,669,663,999
- PACER ADVISORS, INC. removed 2,190,191 shares (-99.4%) from their portfolio in Q1 2025, for an estimated $609,070,215
- CASTLEKEEP INVESTMENT ADVISORS LLC removed 1,770,389 shares (-99.6%) from their portfolio in Q1 2025, for an estimated $492,327,477
- BLACKROCK, INC. added 1,586,251 shares (+9.7%) to their portfolio in Q1 2025, for an estimated $441,120,540
- INVESCO LTD. added 1,364,433 shares (+42.1%) to their portfolio in Q1 2025, for an estimated $379,435,172
- VIKING GLOBAL INVESTORS LP added 1,067,819 shares (+inf%) to their portfolio in Q1 2025, for an estimated $296,949,785
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 975,362 shares (+4459.6%) to their portfolio in Q1 2025, for an estimated $271,238,418
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CENCORA Insider Trading Activity
CENCORA insiders have traded $COR stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $COR stock by insiders over the last 6 months:
- BOOTS ALLIANCE, INC. WALGREENS has made 0 purchases and 2 sales selling 1,286,376 shares for an estimated $314,531,795.
- STEVEN H COLLIS (Executive Chairman) has made 0 purchases and 7 sales selling 72,893 shares for an estimated $20,247,626.
- ROBERT P. MAUCH (President & CEO) has made 0 purchases and 7 sales selling 24,847 shares for an estimated $6,917,314.
- SILVANA BATTAGLIA (Executive Vice President) has made 0 purchases and 2 sales selling 9,077 shares for an estimated $2,423,720.
- LAZARUS KRIKORIAN (SVP & Chief Accounting Officer) has made 0 purchases and 3 sales selling 5,000 shares for an estimated $1,387,000.
- ELIZABETH S CAMPBELL (Executive Vice President) has made 0 purchases and 2 sales selling 4,127 shares for an estimated $1,107,191.
- LON R GREENBERG sold 3,000 shares for an estimated $837,150
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CENCORA Government Contracts
We have seen $138,559 of award payments to $COR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PHARMACY ORDER WELIREG 40MG: $22,051
- PHARMACY ORDER BALVERSA 4MG TABLETS: $18,125
- PHARMACY ORDER BALVERSA 4MG TABS: $18,125
- PHARMACY ORDER BALVERSA 4MG TABS: $17,642
- PHARMACY ORDER BALVERSA 4MG TABS: $17,642
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
CENCORA Congressional Stock Trading
Members of Congress have traded $COR stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $COR stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $100,000 on 05/12.
- REPRESENTATIVE GREG LANDSMAN sold up to $50,000 on 03/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CENCORA Analyst Ratings
Wall Street analysts have issued reports on $COR in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 06/03/2025
- Citigroup issued a "Buy" rating on 05/08/2025
- Baird issued a "Outperform" rating on 05/08/2025
- UBS issued a "Buy" rating on 04/29/2025
- Evercore ISI Group issued a "Outperform" rating on 02/06/2025
- JP Morgan issued a "Overweight" rating on 01/24/2025
To track analyst ratings and price targets for CENCORA, check out Quiver Quantitative's $COR forecast page.
CENCORA Price Targets
Multiple analysts have issued price targets for $COR recently. We have seen 9 analysts offer price targets for $COR in the last 6 months, with a median target of $301.0.
Here are some recent targets:
- Jonathan Petersen from Jefferies set a target price of $300.0 on 06/30/2025
- Stephen Baxter from Wells Fargo set a target price of $337.0 on 06/03/2025
- Michael Rollins from Citigroup set a target price of $355.0 on 05/08/2025
- David Rodgers from Baird set a target price of $350.0 on 05/08/2025
- Kevin Caliendo from UBS set a target price of $335.0 on 04/29/2025
- Michael Funk from B of A Securities set a target price of $285.0 on 04/11/2025
- John Belton from Evercore ISI Group set a target price of $280.0 on 02/06/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $COR ticker page for more data.
